Jove
Visualize
Contact Us

Related Experiment Videos

Human defenses against Cryptococcus neoformans: an update.

E Brummer1

  • 1Department of Medicine, California Institute for Medical Research, Santa Clara Valley Medical Center, San Jose, USA. E.Brummer@JUNO.com

Mycopathologia
|June 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Voriconazole, a new wide-spectrum antifungal triazole: Activity in vitro and in vivo.

Revista iberoamericana de micologia·2008
Same author

Fungicidal activity of human peripheral blood leukocytes against Paracoccidioides brasiliensis yeast cells.

Medical mycology·2005
Same author

Interaction between conidia, lung macrophages, immunosuppressants, proinflammatory cytokines and transcriptional regulation.

Medical mycology·2005
Same author

Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.

Medical mycology·2003
Same author

Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.

Medical mycology·2002
Same author

Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia.

Medical mycology·2002
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Cryptococcus neoformans, a fungal pathogen, particularly affects AIDS patients. The body

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Cryptococcus neoformans var. neoformans is a global opportunistic fungal pathogen, notably affecting individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • Cryptococcus neoformans var. gatti (CN-g) has a more restricted ecological niche, primarily associated with specific Eucalyptus tree species.
  • Alveolar macrophages (AM) represent the initial defense against Cryptococcus neoformans, providing a degree of resistance.

Purpose of the Study:

  • To define the inflammatory response and cytokine secretion by human alveolar macrophages (AM) during Cryptococcus neoformans infection.
  • To elucidate the roles of different immune cell populations and cytokines in host defense against Cryptococcus neoformans.

Main Methods:

  • The abstract does not specify the methods used in the study.

Related Experiment Videos

Main Results:

  • The inflammatory response, involving neutrophils and monocytes, constitutes a second line of defense, with inflammatory phagocytes demonstrating efficient killing of Cryptococcus neoformans.
  • T and B cell responses, including lymphokine (e.g., Interferon-gamma) and specific antibody production, form a third line of defense.
  • Interleukin-12 (IL-12) and Interleukin-18 (IL-18) enhance lymphocyte responses, appearing critical for controlling Cryptococcus neoformans infection.

Conclusions:

  • Alveolar macrophages and subsequent inflammatory cell influx are crucial for controlling Cryptococcus neoformans.
  • Adaptive immune responses, particularly T and B cell functions enhanced by IL-12 and IL-18, are vital for host defense.
  • AIDS patients' susceptibility is linked to low CD4+ T cell counts, compromising immune defenses against Cryptococcus neoformans.